An article in the New York Times is reporting that Dr. Dipak Das (U. Connecticut), is under investigation for scientific misconduct – specifically, for reporting fraudulent data. Dr. Das was one of the early contributors to research on Resveratrol, a potential anti-aging compound upon which millions of research dollars have since been spent. Many experts on Resveratrol were unaware of Dr. Das and his work until the reports of fraudulent data surfaced. Although much research since Resveratrol’s beginning has had positive results, scientific misconduct is a serious issue and can adversely impact not only the progress of the field, but can waste millions of dollars of taxpayer money. Read the article at the New York Times here and one in the Chronicle of Higher Education here, and a WordPress blog on the situation here.